• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
93.2373503
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
144.46
433619.81
EPS(TTM)
Face Value()
Div & Yield %
12.51
1
0.89
 

restaurant br&s asia ltd
Info Edge (India) to invest Rs 30 cr in Startup Investments (Holding)
May 18,2026
Info Edge (India) will invest about Rs 30 crore in its wholly owned subsidiary, Startup Investments (Holding) (SIHL). The present investment would help SIHL to explore investment opportunities including contribution to AIF(s) and other general purposes.

The company has agreed to acquire 14,01,214 0.0001% Compulsorily Convertible Debentures (CCDs) at an issue price of Rs. 214.10/- each including premium of Rs. 114.10/- per CCD. Post this investment, SIHL remains the wholly owned subsidiary of the company.